Gossamer Bio
GOSS
#9903
Rank
NZ$0.14 B
Marketcap
NZ$0.29
Share price
-3.03%
Change (1 day)
-89.97%
Change (1 year)

Revenue for Gossamer Bio (GOSS)

Revenue in 2026 (TTM): NZ$95.07 Million

According to Gossamer Bio's latest financial reports the company's current revenue (TTM ) is NZ$94.38 Million. In 2025 the company made a revenue of NZ$83.69 Million a decrease over the revenue in the year 2024 that were of NZ$0.20 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Gossamer Bio from 2018 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) NZ$95.07 M13.6%
2025 NZ$83.69 M-58.85%
2024 NZ$0.20 B
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA